Geron Corp. buy BiotechBee
Start price
03.03.24
/
70%
€2.10
Target price
31.08.26
€3.70
Performance (%)
68.48%
Price
26.04.24
€3.54
Summary
This prediction is currently active. With a performance of 68.48% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 31.08.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Geron Corp. | 2.018% | 2.018% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to BiotechBee what are the pros and cons of Geron Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Geron Corp. diskutieren
Stopped prediction by BiotechBee for Geron Corp.
Geron Corp.
Start price
Target price
Perf. (%)
€2.88
24.06.23
24.06.23
€4.00
30.04.26
30.04.26
-27.18%
03.03.24
03.03.24
Could be very worthwhile Investment >20% year
Geron Corp.
Start price
Target price
Perf. (%)
€2.50
04.01.23
04.01.23
€6.00
31.12.25
31.12.25
38.38%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year